Move over, psoriasis drug marketers—Tremfya has joined the broadcast. The next-generation biologic from Johnson & Johnson's Janssen began airing its first DTC campaign two weeks ago, joining two other new-age drugs already tearing up the psoriasis market and grabbing TV time.Original Article
Johnson & Johnson joins psoriasis rivals Novartis, Lilly on the tube with new Tremfya ad
